3 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Advanced Tumors: new trials by email Literature Review of Advanced Tumors trials Research Report on Advanced Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A SHR-1210 BE Study on Healthy Subjects SHR-1210 - Advanced Tumors | Phase 1 | Terminated | Jiangsu HengRui Medicine Co., Ltd. | 12 | 2023-07-04 | 2024-12-31 |
| A Study of HRS2543 in Patients With Advanced Tumors HRS2543 - Advanced Tumors | Phase 1 | Terminated | Shanghai Hengrui Pharmaceutical Co., Ltd. | 10 | 2021-12-28 | 2024-07-18 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors HH2710 - Advanced Tumors, Melanoma | Phase 1 / Phase 2 | Terminated | Haihe Biopharma Co., Ltd. | 37 | 2020-01-07 | 2024-07-19 |
Carcinoma, Non-Small-Cell Lung (1) · Erdheim-Chester Disease (1) · Melanoma (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Hemic and Lymphatic Diseases (1) · Histiocytosis (1) · Histiocytosis, Non-Langerhans-Cell (1) · Lung Diseases (1) · Lung Neoplasms (1) · Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1)
camrelizumab (1)
Haihe Biopharma Co., Ltd. (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Shanghai Hengrui Pharmaceutical Co., Ltd. (1)
China (3) · United States (1)